Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
    • Webcasts & Presentations
    • ASLAN A4 KOL series
    • News Releases
    • Shareholders Meetings
  • Financial Information
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

ASLAN A4 Series: Aspects of Atopic Dermatitis and ASLAN004 (eblasakimab)

ASLAN A4 Series: Aspects of Atopic Dermatitis and ASLAN004 (eblasakimab)

ASLAN’s A4 webinar series: ‘Dialogues with International Thought Leaders in Dermatology’ featured a series of Key Opinion Leader (KOL) events on the emerging Atopic Dermatitis (AD) landscape and ASLAN004 (eblasakimab)

  • jonathan

    Jonathan Silverberg, MD PhD MPH

    Heterogeneity in AD
    Associate Professor of Dermatology
    George Washington University School of Medicine and Health Sciences

    Episode 1: 25 Oct 2021
    Accompanying slides, A4 KOL Series: Episode 1, Jonathan Silverberg
    • april

      April Armstrong, MD MPH

      A closer look: Key factors impacting responses in AD clinical trials
      Professor of Dermatology and Associate Dean
      University of Southern California

      Episode 2: 20 Jan 2022
      Accompanying slides, A4 KOL Series: Episode 2, April Armstrong
      • peter

        Peter Lio, MD

        AD: Patient journeys and unmet needs
        Clinical Assistant Professor of Dermatology and Pediatrics,
        Northwestern University Fienberg School of Medicine

        Episode 3: 22 June 2022
        Accompanying slides, A4 KOL Series: Episode 3, Peter Lio

        Shareholder Tools

        • Print Page

          Print Page

        • RSS Feeds

          RSS Feeds

        • E-mail Alerts

          E-mail Alerts

        Company

        • Pipeline
        • Our Team
        • Investor Relations
        • News & Publications
        • Contact
        • Terms and Conditions

        Careers

        For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

        Contact Us

        Singapore Headquarters
        83 Clemenceau Avenue
        #12-03 UE Square
        Singapore 239920
        Tel: +65 6222 4235
        Fax: +65 6225 2419

        contact@aslanpharma.com